FATUZZO, Pasquale Mario
 Distribuzione geografica
Continente #
NA - Nord America 7.290
EU - Europa 3.054
AS - Asia 2.372
SA - Sud America 447
AF - Africa 234
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 13.406
Nazione #
US - Stati Uniti d'America 6.984
SG - Singapore 1.268
CN - Cina 882
IE - Irlanda 803
UA - Ucraina 785
IT - Italia 724
BR - Brasile 418
CA - Canada 288
RU - Federazione Russa 220
DE - Germania 180
CI - Costa d'Avorio 177
SE - Svezia 97
IN - India 79
GB - Regno Unito 70
FR - Francia 43
SN - Senegal 29
VN - Vietnam 28
CH - Svizzera 23
AT - Austria 21
UZ - Uzbekistan 21
BD - Bangladesh 20
AR - Argentina 18
NL - Olanda 16
GR - Grecia 15
PL - Polonia 15
TR - Turchia 13
MX - Messico 11
ZA - Sudafrica 10
IQ - Iraq 9
AL - Albania 8
MA - Marocco 8
FI - Finlandia 7
IR - Iran 7
LB - Libano 7
ES - Italia 6
JP - Giappone 6
PK - Pakistan 5
CO - Colombia 4
EU - Europa 4
KR - Corea 4
NP - Nepal 4
PT - Portogallo 4
AU - Australia 3
BB - Barbados 3
EG - Egitto 3
HK - Hong Kong 3
HU - Ungheria 3
KE - Kenya 3
LT - Lituania 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
KW - Kuwait 2
OM - Oman 2
SA - Arabia Saudita 2
SM - San Marino 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.406
Città #
Houston 1.256
Santa Clara 984
Jacksonville 866
Dublin 802
Singapore 761
Chandler 712
Boardman 347
Chicago 292
Nanjing 268
Andover 234
Lawrence 233
Cambridge 231
Toronto 218
Abidjan 177
Des Moines 134
Ashburn 130
San Mateo 117
Catania 112
Wilmington 102
Grafing 93
Nanchang 81
Beijing 80
Shenyang 80
Saint Petersburg 76
Civitanova Marche 59
Hebei 57
Ottawa 51
Jiaxing 50
Council Bluffs 48
Los Angeles 45
Changsha 43
Hefei 41
Rome 41
Tianjin 38
Bremen 33
Dakar 29
Kochi 28
São Paulo 27
Milan 24
New York 23
Seattle 22
Rio de Janeiro 21
Pune 20
The Dalles 20
Dong Ket 18
Brooklyn 17
Columbus 17
Moscow 16
Norwalk 15
Hangzhou 13
Florence 12
Padova 12
San Francisco 12
Boston 11
Kunming 11
Ningbo 11
Noto 11
Zhengzhou 11
Charlotte 10
Liberty Lake 10
Nuremberg 10
Civitavecchia 9
Guangzhou 9
Guarulhos 9
Jinan 9
London 9
Carlentini 8
Curitiba 8
Dhaka 8
Monteiasi 8
Montreal 8
Mumbai 8
Palermo 8
Recife 8
Messina 7
Munich 7
Sorocaba 7
Tirana 7
Washington 7
Amsterdam 6
Ardabil 6
Atlanta 6
Bari 6
Belo Horizonte 6
Brasília 6
Frankfurt Am Main 6
Praia Grande 6
Salvador 6
Taizhou 6
Tokyo 6
Vienna 6
Ann Arbor 5
Cape Town 5
Caxias do Sul 5
Changchun 5
Den Haag 5
Porto Alegre 5
San Giovanni la Punta 5
Secaucus 5
Tashkent 5
Totale 9.584
Nome #
Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients 909
Molecular and clinical studies in five index cases with novel mutations in the GLA gene 277
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis 245
LA DIMETILARGININA ASIMMETRICA (ADMA) INTERAGISCE CON L’FGF-23 NEL PREDIRE LA PROGRESSIONE DEL DANNO RENALE NEI PAZIENTI CON STADIO 2-5 DI MALATTIA RENALE CRONICA 165
Microplastics exposure in dialysis patients: preliminary results of a case-control study 130
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 116
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention 101
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 100
Aferesi terapeutica in paziente con crioglobulinemia (contributo clinico) 96
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease 91
Il Fosforo: nuovo fattore di rischio cardiovascolare? [Phosphorus: A new cardiovascular risk factor?] 90
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 90
Aberrant right subclavian artery laceration due to internal jugular vein catheterization treated by stent -graft implantation 86
A systematic review of arterial stiffness, wave reflection and air pollution 86
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 86
Pazienti con insufficienza renale cronica: risultati dallo studio Nefrodata [Characteristics of patients with chronic kidney disease referred to a nephrology outpatient clinic: results of Nefrodata study] 83
Eventi avversi e trigger C12: Stroke in ospedale 82
Soluble E-selectina is an marker of outcome in end renal disease and interacts with inflammation to determine cardiovascular risk 81
Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: A prospective cohort study in outpatient renal clinics 81
ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVELS IN CHRONIC KIDNEY DISEASE: A SALTY QUESTION? 80
Arteriovenous fistula and pre-surgery mapping: Potential role of physical exercise on endothelial function 80
ADPKD: valutazione di patologia cistica epididimaria e quadro spermatico 79
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” . 78
Rapporti dei peptidi natriuretici con la struttura e la funzione cardiaca nell'insufficienza renale cronica terminale: analogie e differenze tra ANP, BNP, CNP e DNP. 78
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 77
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients 76
Utilità dell’sCD14-ST per la diagnosi di sepsi nel paziente con insufficienza renale [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure] 75
Wegener: nostro contributo clinico 74
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease 74
raised Asymmetric Dimethyl Arginine is Associated With High Plasma Norepinephrine in Patients with ESRD 73
LIVELLI PLASMATICI DELLE PENTRAXINE “SHORT” (PROTEINA C REATTIVA) E DELLE PENTRAXINE “LONG” (PTX3) NELLA INSUFFICIENZA RENALE E NEL TRATTAMENTO EMODIALITICO 73
L’IMMUNITÀ INNATA E LA PROGRESSIONE DELLA MALATTIA RENALE CRONICA 73
Vascular dysfunction in Cardiorenal Syndrome type 4 73
Letter regarding the article "The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study". 72
Asymmetric dimethylarginine (ADMA),left ventricular hypertrophy and systolic dysfunction in hemodialysis patients 72
Arterial pressure determinant of LVH in uremic patients. 72
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 71
Alterazioni carotidee in corso di insufficienza renale cronica 71
Peritonite da Candida e sepsi da Acinetobacter baumannii in dialisi peritoneale: una associazione con la prognosi non è sempre sfavorevole 70
Review: UPDATE sul metabolismo del magnesio 70
Atrial Natriuretic Peptide (ANP), Brain Natriuretic Peptide (BNP) and Left Atrial Volume: a longitudinal study in End Stage Renal Disease (ESRD) patients. JASN 2008;19:719A. 70
Alterazioni carotidee nell’insufficienza renale cronica 69
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism 68
ITALIAN AUDIT ON THERAPY OF HYPERTENSION IN CHRONIC KIDNEY DISEASE: TABLE-CKD STUDY 68
La PET con C-Metionina: un approccio propositivo nel trattamento dell'iperparatiroidismo 68
Valutazione clinica dell'efficacia terapeutica dell'acebutololo nell'ipertensione arteriosa. 68
Metformin and kidney 68
Heart rate, age and the risk progression to kidney failure in patients with CKD 67
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients 67
IL2 and its receptors in elderly subjects on hemodialysis 67
Complicanze tardive legate al posizionamento del catetere venoso centrale: le complicanze meccaniche 67
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease 67
Aspergillosis in Hemodialysis Patient 66
An Unusual Association: Fahr's Syndrome And Chronic Kidney Disease 66
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 66
Ruolo della Dialisi Peritoneale nel trattamento dei Pazienti con Scompenso Cardiaco Congestizio 65
Sepsi e Polimixina (contributo) 65
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 65
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure 65
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease 65
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 65
Comparative study of biochemical markers of bone formation in relation to different dialysis age 64
DIAGNOSTIC POTENZIAL OF CARDIAC NATRIURETIC PEPTIDES IN DIALYSIS PATIENTS 64
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients. 64
Comportamento delle transaminasi sieriche in corso di infezione da HBV e HCV in pazienti emodializzati 63
Magnesium, calcium and potassium: "no one was born alone" 63
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? 62
Psichiatria di Liaison:Contributo sperimentale allo studio della Qualità di dei DializzatiVita 62
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 62
Ultrasuoni versus rx nella dislocazione del catetere peritoneale: mito o raltà? 62
L’interleuchina-6 è implicata in maniera causale nell’alto rischio cardiovascolare della malattia renale cronica: uno studio di randomizzazione mendeliana 62
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients 62
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 62
Renal transplantation parenchymal complications: what Doppler ultrasound can and cannot do 61
Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study 61
CHLAMYDIA PNEUMONIAE, OVERALL AND CARDIOVASCULAR MORTALITY IN END STAGE RENAL DISEASE 61
Il fumo, la pressione arteriosa e l'albuminemia sono fattori predittivi indipendenti dal danno vascolare negli uremici in dialisi 61
Color Doppler ultrasound and arteriovenous fistulas for hemodialysis. 61
DOES DIASTOLIC HEART FUNCTION INTERFERE WITH PERITONEAL CA-125 IN CAPD 61
GESTIONE CLINICA DELL’IRC: DATI CAMPANO-SICILIANI DELLO STUDIO TABLE 61
MANUALE ITALIANO DI CATETERISMO VENOSO CENTRALE IN NEFROLOGIA 61
The effect of tumor necrosis factor antagonists on functional aortic stiffening 61
Ascessi Renali:patologia emergente in soggetti di giovane età 61
Oi Dialogoi in Dialisi Peritoneale 61
Diagnosis of renovascular disease by extra-end intrarenal doppler parameters 60
STUDIO SIR-SIN ( STUDIO ITALIANO INDICATORI DI RISULTATO MULTIPLI-EPIDEMIOLOGIA DELL’IRC IN ITALIA DELLA SOCIETA’ ITALIANA DI NEFROLOGIA) NELLA POPOLAZIONE AFFETTA DA IRC IN TERAPIA CONSERVATIVA. DATI PRELIMINARI 60
Pyelonephritis: Epidemiology, pathogenesis and managemen 60
Exit-site infetto con Proud-Flesh:quale terapia? 60
ADPKD:rilevanza del rischio cardio-vascolare in un gruppo di pazienti non complianti alla terapia antipertensiva. 60
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 60
LE NUOVE SOLUZIONI IN DIALISI PERITONEALE 59
Digoxin and Hypermagnesuria 59
Renal function and ultrasound imaging in elderly subjects 59
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the excite trial 58
Prospective Study of Neuropeptide Y as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease 58
Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease 58
THE ENDOGENOUS INHIBITOR OFF e NOs ASIMMETRIC DIMETHYLARGININE (ADMA) IS HIGHER IN CAPD THAN IN HD PATIENTS 58
L'anziano dializzato " solo ". 58
Il paradosso nefrologico 58
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients 57
Totale 8.323
Categoria #
all - tutte 51.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.390 0 131 186 34 365 39 168 10 217 12 175 53
2021/20221.678 225 251 4 22 263 12 246 63 166 1 41 384
2022/20232.295 250 69 36 182 217 458 5 379 594 15 73 17
2023/2024960 62 204 63 61 34 107 26 51 4 38 206 104
2024/20253.779 35 627 241 160 821 400 44 153 331 420 228 319
2025/2026484 419 65 0 0 0 0 0 0 0 0 0 0
Totale 13.794